BioHarvest Sciences Inc.
corporate_fare Company Profile
BioHarvest Sciences Inc. (NASDAQ:BHST) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 17 items for BHST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-29, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for BHST spans 6-K.
Recent high-impact activity:
- BioHarvest Authorizes Buyback of Up to 5% of Shares, Citing Undervaluation
- BioHarvest Q2 Revenue Hits $8.8M, Gross Margin 58%; CDMO Deal Secures 20-Ton Fragrance Production
- BioHarvest Inks 20-Ton Supply Deal for Rare Fragrance, Eyes $20-30M Revenue
- BioHarvest Lands $1.4M Non-Dilutive Grant for AI-Driven Plant-Cell R&D
- BioHarvest Sciences to Present at BIO International Convention, Seeking Partnerships
Financial Snapshot
Short Interest & Short Volume
2.29 days to coverFINRA reported short interest of 95,360 shares in BHST as of the September 15, 2026 settlement, a 29.0% increase from the prior period — about 2.3 days to cover at its recent average daily volume. On October 2, 2026, 72.9% of BHST volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for BHST, detected from its recent SEC filings · based on capital-structure filings through 2026-07-15.
$1.4M IIA Grant Formalized · Second IIA Grant in 2026
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
BHST files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.